Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07232758
PHASE1

Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and Multiple Administration

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

View on ClinicalTrials.gov

Summary

This study mainly evaluated the safety and tolerability, as well as the pharmacokinetic characteristics, of the injectable drug HRS-2183 after single and multiple administrations in healthy subjects.

Key Details

Gender

All

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

42

Start Date

2025-10-30

Completion Date

2026-02

Last Updated

2025-11-18

Healthy Volunteers

Yes

Interventions

DRUG

HRS-2183

HRS-2183

DRUG

Placebo

placebo

Locations (1)

Qilu Hospital of Shandong University

Jinan, Shandong, China